COGT

Cogent Biosciences INC

+$999.2M

Net Activity

Institutions Holding

307

Popularity Rank

#1937

Avg Weight

0.54%

Total Value

$7.2B

Ownership Trend

307 institutions currently hold COGT, with 190 net buyers and 119 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

119

Net Buying Institutions

190

Key Holders

View all 307 holding institutions

Quarterly Activity

Recent Activity

+$4.4B

Total Buy Value

$2.2B

Total Sell Value

New buy71
Trim84
Add119
Sold out35

190

Net Buyers

119

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding COGENT BIOSCIENCES INC (COGT)?
Major stakeholders currently include FMR LLC ($890.0M), BlackRock, Inc. ($617.6M), Deerfield Management Company, L.p. ($348.1M). Based on the latest 13F filings, there are a total of 307 tracked investment funds and institutions maintaining positions in COGT.
What is the overall institutional sentiment toward COGT recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $999.2M, driven by 190 managers accumulating shares while 119 reduced their exposure.
Which institutions have been selling or reducing their COGT positions?
In the latest period, 84 funds trimmed their holdings, and 35 managers completely exited their positions. The aggregate reported sell value was $2.2B.
Are there any notable investors adding COGT to their portfolios?
Yes, buying activity remains notable. 71 institutions opened new positions in {ticker}, and 119 existing holders added to their shares. The total reported buy value for the quarter amounted to $4.4B.

Related Stocks